Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to PAH
Related studies linked through entity extraction aliases.
Effects of Pulmonary Rehabilitation on Quality of Life and Health in Pulmonary Arterial Hypertension Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg
- Status
- COMPLETED
- Phase
- PHASE1
Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension
- Status
- UNKNOWN
- Phase
- N/A
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
- Status
- TERMINATED
- Phase
- PHASE3
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
- Status
- COMPLETED
- Phase
- PHASE3
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- PHASE2
Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers
- Status
- WITHDRAWN
- Phase
- PHASE1
Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib
- Status
- WITHDRAWN
- Phase
- N/A
Pulmonary Hypertension and Imatinib
- Status
- COMPLETED
- Phase
- N/A